A De Novo BSCL2 Gene S90L Mutation in a Progressive Tetraparesis with Urinary Dysfunction and Corpus Callosum Involvement

Abstract

A Silver syndrome is a rare autosomal dominant spastic paraparesis in which spasticity of the lower limbs is accompanied by amyotrophy of the small hand muscles. The causative gene is the Berardinelli-Seip congenital lipodystrophy 2 (BSCL2), which is related to a spectrum of neurological phenotypes. In the current study, we presented a 14-year-old male with a slowly progressive spastic paraparesis with urinary incontinence that later on exhibited atrophy and weakness in the thenar and dorsal interosseous muscles. Magnetic resonance imaging (MRI) revealed discrete atrophy of the corpus callosum isthmus and an extended next-generation sequencing panel identified a de novo heterozygous mutation in BSCL2 gene, c.269C > T p.(S90L). Various clinical expression and incomplete penetrance of BSCL2 gene mutations complicate the establishment of a genetic etiology for these cases. Therefore, Silver syndrome should be included in the differential diagnosis if the initial presentation is a spastic paraparesis by urinary involvement with childhood-onset, even with MRI atypical findings. This report described the first Iberian Silver syndrome case carrying a de novo c.269C > T p. (S90L) BSCL2 gene mutation.

Keywords

BSCL2 - Silver syndrome - S90L

Publikationsverlauf

Eingereicht: 19. April 2020

Angenommen: 20. Mai 2020

Artikel online veröffentlicht:
08. Juli 2020

• References

• 1 Musacchio T, Zaum AK, Üçeyler N. et al. ALS and MMN mimics in patients with BSCL2 mutations: the expanding clinical spectrum of SPG17 hereditary spastic paraplegia. J Neurol 2017; 264 (01) 11-20
• 2 Rakocević-Stojanović V, Milić-Rasić V, Perić S. et al. N88S mutation in the BSCL2 gene in a Serbian family with distal hereditary motor neuropathy type V or Silver syndrome. J Neurol Sci 2010; 296 (1-2): 107-109
• 3 Brugman F, Scheffer H, Schelhaas HJ. et al. Seipin/BSCL2 mutation screening in sporadic adult-onset upper motor neuron syndromes. J Neurol 2009; 256 (05) 824-826
• 4 Cen Z, Lu X, Wang Z, Ouyang Z, Xie F, Luo W. BSCL2 S90L mutation in a Chinese family with Silver syndrome with a review of the literature. J Clin Neurosci 2015; 22 (02) 429-430
• 5 Rowland LP, Bird TD. Silver syndrome: the complexity of complicated hereditary spastic paraplegia. Neurology 2008; 70 (21) 1948-1949
• 6 Windpassinger C, Auer-Grumbach M, Irobi J. et al. Heterozygous missense mutations in BSCL2 are associated with distal hereditary motor neuropathy and Silver syndrome. Nat Genet 2004; 36 (03) 271-276
• 7 van de Warrenburg BP, Scheffer H, van Eijk JJ. et al. BSCL2 mutations in two Dutch families with overlapping Silver syndrome-distal hereditary motor neuropathy. Neuromuscul Disord 2006; 16 (02) 122-125
• 8 Rohkamm B, Reilly MM, Lochmüller H. et al. Further evidence for genetic heterogeneity of distal HMN type V, CMT2 with predominant hand involvement and Silver syndrome. J Neurol Sci 2007; 263 (1-2): 100-106
• 9 Patel H, Hart PE, Warner TT. et al. The Silver syndrome variant of hereditary spastic paraplegia maps to chromosome 11q12-q14, with evidence for genetic heterogeneity within this subtype. Am J Hum Genet 2001; 69 (01) 209-215
• 10 Monteiro A, Real R, Nadais G, Silveira F, Leão M. BSCL2 N88S mutation in a Portuguese patient with the Silver syndrome. Muscle Nerve 2015; 51 (03) 456-458
• 11 Cho HJ, Sung DH, Ki CS. Identification of de novo BSCL2 Ser90Leu mutation in a Korean family with Silver syndrome and distal hereditary motor neuropathy. Muscle Nerve 2007; 36 (03) 384-386
• 12 Irobi J, Van den Bergh P, Merlini L. et al. The phenotype of motor neuropathies associated with BSCL2 mutations is broader than Silver syndrome and distal HMN type V. Brain 2004; 127 (Pt 9): 2124-2130
• 13 Poon M, Nguyen TP. Clinical reasoning: childhood-onset atrophy and spasticity. Neurology 2016; 86 (13) e140-e143
• 14 Ito D. BSCL2-related neurologic disorders/seipinopathy summary genetic counseling GeneReview scope. GeneReviews; 2018:1–12. Accessed February 10, 2020 at: https://www.ncbi.nlm.nih.gov/books/NBK1307/
• 15 Braschinsky M, Zopp I, Kals M, Haldre S, Gross-Paju K. Bladder dysfunction in hereditary spastic paraplegia: what to expect?. J Neurol Neurosurg Psychiatry 2010; 81 (03) 263-266
• 16 Franco F, Junqueira T, Rezende R. Neuroimaging in hereditary spastic paraplegias. Curr Use Future Perspect 2019; 9: 1-1117
• 17 Ishihara S, Okamoto Y, Tanabe H. et al. Clinical features of inherited neuropathy with BSCL2 mutations in Japan. J Peripher Nerv Syst 2020; (e-pub ahead of print)
• 18 Fernández-Marmiesse A, Sánchez-Iglesias S, Darling A. et al. A de novo heterozygous missense BSCL2 variant in 2 siblings with intractable developmental and epileptic encephalopathy. Seizure 2019; 71: 161-165
• 19 Yan R, Qian H, Lukmantara I. et al. Human SEIPIN binds anionic phospholipids. Dev Cell 2018; 47 (02) 248-256.e4
• 20 Cui X, Wang Y, Tang Y. et al. Seipin ablation in mice results in severe generalized lipodystrophy. Hum Mol Genet 2011; 20 (15) 3022-3030
• 21 Gao M, Huang X, Song BL, Yang H. The biogenesis of lipid droplets: lipids take center stage. Prog Lipid Res 2019; 75: 100989
• 22 Ito D, Fujisawa T, Iida H, Suzuki N. Characterization of seipin/BSCL2, a protein associated with spastic paraplegia 17. Neurobiol Dis 2008; 31 (02) 266-277